Name
Session V: Novel Delivery Platforms
Date & Time
Monday, September 28, 2026, 2:35 PM - 3:35 PM
Huaqiang Eric Xu, PhD David Scheinberg , MD, PhD
Description

2:35 PM A First-in-Class Pulsatile FXR Agonist for ​Bile-Acid-Related Liver Diseases & Cancers​

Huaqiang Eric Xu, PhD, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

 

3:05 PM Targeted Cellular Micropharmacies and Micropharmacists  

David Scheinberg, MD, PhD, Memorial Sloan Kettering Cancer Center